A composition including a first compound represented by Formula 1 and a second compound represented by Formula 2:

##STR00001##

wherein in Formula 1, M.sub.1 is Pt, Pd, or Au, in Formula 2, M.sub.2 is Ir, L.sub.11 is a ligand represented by Formula 2-1, L.sub.12 is a ligand represented by Formula 2-2, L.sub.13 is a ligand represented by Formula 2-1 or 2-2, L.sub.11 and L.sub.12 are different from each other, n11, n12, and n13 are each independently 0, 1, 2, or 3, and a sum of n11+n12+n13 is equal to 3, and wherein the remaining substituent groups are each understood by referring to the detailed description provided herein.

An organometallic compound represented by Formula 1 emits deep blue light. A light-emitting device including the organometallic compound, and an electronic apparatus including the light-emitting device may have excellent or suitable driving voltage, luminescence efficiency, color conversion efficiency, and/or lifespan characteristics:

##STR00001##

In Formula 1, X.sub.1 to X.sub.4 are each independently C or N, Y.sub.11 is C(Z.sub.11) or N, and Y.sub.12 is C(Z.sub.12) or N.

An organometallic compound is represented by Formula 1. A light-emitting device includes a first electrode, a second electrode facing the first electrode, an interlayer disposed between the first electrode and the second electrode and including an emission layer, and at least one organometallic compound represented by Formula 1. An electronic apparatus includes the light-emitting device.

A compound of Formula I,

##STR00001##

is disclosed. In Formula I, M is Pd or Pt; each of X.sup.1 to X.sup.12 is C or N; each of X.sup.13 and X.sup.14 is CH, CD or N; each of Z.sup.1, Z.sup.2, and Z.sup.3 is C or N; L.sup.1 is selected from a variety of bivalent linkers; X is selected from O, S, Se, NR′, and CR″R′″; each R, R′, R.sup.1, R.sup.2, R.sup.3, R.sup.A, R.sup.B, R.sup.C, R.sup.D, and R.sup.E is hydrogen or a General Substituent; at least one of Z.sup.1, Z.sup.2, and Z.sup.3 is a carbon atom substituted with a substituent with a molecular weight of at least 16. Formulations, OLEDs, and consumer products that include Formula I are also disclosed.

Disclosed herein are a novel organometallic compound and an organic light-emitting diode including same. More specifically, an organometallic compound represented by [Chemical Formula 1] and an organic light-emitting diode including same are provided.

Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

Provided is an organometallic complex including a ligand L.sub.A having a structure represented by one of the following formulas ##STR00001##
and coordiated to Ir.

Platinum, palladium, and gold tetradentate metal complexes of Formulas I and II including indoloacridine.

##STR00001##

The complexes are suitable for use as phosphorescent or delayed fluorescent and phosphorescent emitters in display and lighting applications.

Metal-assisted delayed fluorescent (MADF) emitters including cyclic tetradentate platinum (II) and palladium (II) complexes employing 8H-pyrido[3′,2′:4,5]-pyrrolo[3,2,1-de]acridine and its analogues. These complexes provide improved color purity and enhanced operational stability and are suitable for luminescent labels, emitters for organic light emitting diodes (OLEDs), and lighting applications.

An organometallic compound represented by Formula 1A:

##STR00001##

wherein, in Formula 1A, groups and variables are the same as described in the specification.